Nitric oxide (no) synthase inhibitor to treat or prevent...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/195 (2006.01) A61K 31/155 (2006.01) A61K 31/198 (2006.01)

Patent

CA 2240396

A method for the treatment and/or prophylaxis of Type II diabetes, which method comprises the administration, to a human or non-human mammal, of an effective non-toxic pharmaceutically acceptable amount of an NO synthase inhibitor, such as aminoguanidine, or a pharmaceutically acceptable derivative thereof.

L'invention concerne un procédé pour le traitement et/ou la prophylaxie du diabète de type II, ledit procédé consistant à administrer à un mammifère humain ou non, une quantité efficace, non toxique et pharmaceutiquement acceptable, d'un inhibiteur de la NO synthase, par exemple l'aminoguanidine, ou d'un dérivé pharmaceutiquement acceptable dudit inhibiteur.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Nitric oxide (no) synthase inhibitor to treat or prevent... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nitric oxide (no) synthase inhibitor to treat or prevent..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitric oxide (no) synthase inhibitor to treat or prevent... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1777464

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.